《大行報告》匯豐研究上調協鑫科技(03800.HK)目標價至5元 評級「買入」
匯豐研究發表報告指,近日到訪協鑫科技(03800.HK)位於四川樂山的新工廠視察,與投資者討論後,對新工廠反應正面。該行預料,位於包頭的新工廠將於今年11月投產,會為公司額外提供10萬噸工業矽產量;除了現有的渠道產能,公司計劃透過進一步開設其他生產工廠,以達致每年產量為20至30萬噸。
該行表示,鑑於海外市場對太陽能需求增加,公司正尋求於海外開設工廠,同時亦考慮未來與下游客戶共同投資旗下的工廠。該行上調集團2022年至23年盈利預測25%至28%,高於市場預測的10%至69%,並將其目標價由4.7元上調至5元,維持評級「買入」。(ca/k)
~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.